Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2026)

Harmony Biosciences Holdings has disclosed Inventory Average across 7 years of filings, most recently posting $5.5 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $5.5 million, down 20.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 million (down 20.22% YoY), and the FY2025 annual result was $6.4 million, up 1.26% from the prior year.
• Inventory Average came in at $5.5 million for Q1 2026 at Harmony Biosciences Holdings, down from $6.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $7.1 million in Q4 2024 to a low of $4.2 million in Q1 2023.
• The 5-year median for Inventory Average is $5.5 million (2026), against an average of $5.5 million.
• Across the five-year window, Inventory Average surged 33.78% in 2024 and dropped 20.22% in 2026, its largest moves.
• Harmony Biosciences Holdings' Inventory Average stood at $4.4 million in 2022, then advanced by 21.47% to $5.4 million in 2023, then surged by 31.42% to $7.1 million in 2024, then decreased by 12.12% to $6.2 million in 2025, then decreased by 11.59% to $5.5 million in 2026.
• The last three Inventory Average figures came in at $5.5 million (Q1 2026), $6.2 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.